SCHEMBL3409919

SCHEMBL3409919

CCCCC1(N(C)C)CCN(CCN(C)Cc2cccc3[nH]ccc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.47
SIGMAR1 Q99720 3/20 0.41
OPRM1 P35372 4/20 0.35
OPRL1 P41146 3/20 0.35
ACHE P22303 2/20 0.35
HTR6 P50406 1/20 0.34
OPRK1 P41145 2/20 0.34
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
DRD1 P21728 1/20 0.34
DRD4 P21917 1/20 0.34
DRD5 P21918 1/20 0.34
HTR1A P08908 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405023 0.87 BCHE (0.48) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL3410720 0.84 SIGMAR1 (0.41) SIGMAR1OPRM1OPRL1HTR1A
SCHEMBL3403549 0.80 OPRL1 (0.49) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL3405528 0.79 SIGMAR1 (0.41) SIGMAR1OPRM1OPRL1ACHE
SCHEMBL3407864 0.78 KCNH2 (0.41) SIGMAR1ACHE
SCHEMBL3407016 0.78 HTR1A (0.49) BCHESIGMAR1DRD2DRD3DRD1
SCHEMBL3408077 0.77 BCHE (0.48) BCHESIGMAR1OPRM1OPRL1ACHE
SCHEMBL13284397 0.75 BCHE (0.64) BCHEACHEHTR1A
SCHEMBL4103472 0.72 SMN1; SMN2 (0.59) OPRL1DRD2DRD3DRD1DRD4
SCHEMBL3404191 0.71 TACR2 (0.46) OPRL1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP claimed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 BCHE 2840/4885SIGMAR1 235/4885OPRM1 30/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 BCHE 2840/4885SIGMAR1 235/4885OPRM1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.